NO990722L - Fremgangsmåte for behandling av hjertesvikt - Google Patents

Fremgangsmåte for behandling av hjertesvikt

Info

Publication number
NO990722L
NO990722L NO990722A NO990722A NO990722L NO 990722 L NO990722 L NO 990722L NO 990722 A NO990722 A NO 990722A NO 990722 A NO990722 A NO 990722A NO 990722 L NO990722 L NO 990722L
Authority
NO
Norway
Prior art keywords
heart failure
treatment
procedure
phenoxy
trimethyl
Prior art date
Application number
NO990722A
Other languages
English (en)
Norwegian (no)
Other versions
NO990722D0 (no
Inventor
Yuhpyng Liang Chen
Anthony Andrea Fossa
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO990722D0 publication Critical patent/NO990722D0/no
Publication of NO990722L publication Critical patent/NO990722L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO990722A 1998-02-17 1999-02-16 Fremgangsmåte for behandling av hjertesvikt NO990722L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7493498P 1998-02-17 1998-02-17

Publications (2)

Publication Number Publication Date
NO990722D0 NO990722D0 (no) 1999-02-16
NO990722L true NO990722L (no) 1999-08-18

Family

ID=22122537

Family Applications (1)

Application Number Title Priority Date Filing Date
NO990722A NO990722L (no) 1998-02-17 1999-02-16 Fremgangsmåte for behandling av hjertesvikt

Country Status (28)

Country Link
US (1) US6043260A (bg)
EP (1) EP0951906A1 (bg)
JP (1) JPH11292766A (bg)
KR (1) KR19990072616A (bg)
CN (1) CN1231176A (bg)
AP (1) AP9901464A0 (bg)
AR (1) AR017723A1 (bg)
AU (1) AU1732999A (bg)
BG (1) BG103180A (bg)
BR (1) BR9900653A (bg)
CA (1) CA2262252C (bg)
EA (1) EA199900124A3 (bg)
GT (1) GT199900015A (bg)
HR (1) HRP990054A2 (bg)
HU (1) HUP9900386A3 (bg)
ID (1) ID23218A (bg)
IL (1) IL128531A0 (bg)
IS (1) IS4975A (bg)
MA (1) MA26608A1 (bg)
NO (1) NO990722L (bg)
OA (1) OA10976A (bg)
PA (1) PA8467401A1 (bg)
PE (1) PE20000266A1 (bg)
PL (1) PL331507A1 (bg)
SG (1) SG81261A1 (bg)
TN (1) TNSN99024A1 (bg)
TR (1) TR199900328A2 (bg)
ZA (1) ZA991220B (bg)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403599B1 (en) 1995-11-08 2002-06-11 Pfizer Inc Corticotropin releasing factor antagonists
US7067664B1 (en) 1995-06-06 2006-06-27 Pfizer Inc. Corticotropin releasing factor antagonists
US6956047B1 (en) 1995-06-06 2005-10-18 Pfizer Inc. Corticotropin releasing factor antagonists
US6387894B1 (en) * 1999-06-11 2002-05-14 Pfizer Inc. Use of CRF antagonists and renin-angiotensin system inhibitors
WO2001021259A2 (en) * 1999-09-21 2001-03-29 Emory University Use and compositions for treating platelet-related disorders using anagrelide
CA2397633A1 (en) * 2000-01-18 2001-07-26 Pfizer Products Inc. Corticotropin releasing factor antagonists
US6737430B2 (en) 2000-11-09 2004-05-18 Pfizer, Inc. Mutual prodrug of amlodipine and atorvastatin
GB0027410D0 (en) * 2000-11-09 2000-12-27 Pfizer Ltd Mutual prodrug of amlodipine and atorvastatin
US6992087B2 (en) 2001-11-21 2006-01-31 Pfizer Inc Substituted aryl 1,4-pyrazine derivatives
CA2477008A1 (en) 2002-02-22 2003-09-04 Pharmacia & Upjohn Company Substituted pyrimidinones and pyrimidinthiones
BR0308391A (pt) * 2002-03-13 2005-01-11 Pharmacia & Upjohn Co Llc Derivados de pirazolo(1,5-a)piridina como moduladores neurotransmissores
WO2003091225A1 (en) * 2002-04-26 2003-11-06 Pharmacia & Upjohn Company Substituted pyrazine derivatives
WO2004024719A1 (en) * 2002-09-12 2004-03-25 Pharmacia & Upjohn Company Llc Substituted 1,4-pyrazine derivatives
AR041470A1 (es) * 2002-10-17 2005-05-18 Upjohn Co Compuestos de pirrolo (1,2 - b) piridazina y sus usos
JP2006514628A (ja) * 2002-11-21 2006-05-11 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー Ｃｒｆ変調剤としてのピラジン化合物
BRPI0409649A (pt) * 2003-04-23 2006-04-25 Pharmacia & Upjohn Co Llc pirimidinonas e pirimidinotionas substituìdas como antagonistas de crf
JP2006525309A (ja) * 2003-05-07 2006-11-09 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー ピロロ（１，２−ｂ）ピリダジン化合物、ならびにＣＲＦ−１受容体拮抗薬としてのその使用
MXPA05012081A (es) * 2003-05-09 2006-02-22 Pharmacia & Upjohn Co Llc Derivados de pirimidina sustituidos.
EP1625125A1 (en) * 2003-05-09 2006-02-15 Pharmacia & Upjohn Company LLC Compounds as crf1 receptor antagonists
WO2004099161A1 (en) * 2003-05-09 2004-11-18 Pharmacia & Upjohn Company Llc Pyrazinones as crf1 receptor antagonists for the treatment of cns disorders
WO2005089639A2 (en) * 2004-03-16 2005-09-29 Talarico M D Matthew T Method for vascular dysregulation
US20060211710A1 (en) * 2005-03-17 2006-09-21 Pfizer Inc Substituted aryl 1,4-pyrazine derivatives
US8338441B2 (en) * 2009-05-15 2012-12-25 Gilead Sciences, Inc. Inhibitors of human immunodeficiency virus replication

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW530047B (en) * 1994-06-08 2003-05-01 Pfizer Corticotropin releasing factor antagonists
US6403599B1 (en) * 1995-11-08 2002-06-11 Pfizer Inc Corticotropin releasing factor antagonists
EP0795327A1 (en) * 1996-03-13 1997-09-17 Pfizer Inc. Use of Amlodipine for the treatment and prophylaxis of congestive cardiac failure of non-ischaemic origin

Also Published As

Publication number Publication date
TNSN99024A1 (fr) 2005-11-10
EA199900124A3 (ru) 1999-12-29
AU1732999A (en) 1999-09-02
ID23218A (id) 2000-03-30
KR19990072616A (ko) 1999-09-27
IL128531A0 (en) 2000-01-31
HUP9900386A3 (en) 1999-12-28
BG103180A (bg) 1999-09-30
MA26608A1 (fr) 2004-12-20
NO990722D0 (no) 1999-02-16
HUP9900386A2 (hu) 1999-11-29
EP0951906A1 (en) 1999-10-27
BR9900653A (pt) 2000-10-17
IS4975A (is) 1999-08-18
HRP990054A2 (en) 2000-02-29
AR017723A1 (es) 2001-09-12
CN1231176A (zh) 1999-10-13
CA2262252C (en) 2006-01-10
SG81261A1 (en) 2001-06-19
US6043260A (en) 2000-03-28
GT199900015A (es) 2000-07-26
HU9900386D0 (en) 1999-04-28
PE20000266A1 (es) 2000-04-07
TR199900328A2 (xx) 1999-10-21
OA10976A (en) 2001-11-05
CA2262252A1 (en) 1999-08-17
EA199900124A2 (ru) 1999-08-26
JPH11292766A (ja) 1999-10-26
PL331507A1 (en) 1999-08-30
PA8467401A1 (es) 2000-09-29
AP9901464A0 (en) 1999-03-31
ZA991220B (en) 2000-08-16

Similar Documents

Publication Publication Date Title
NO990722L (no) Fremgangsmåte for behandling av hjertesvikt
MD970253A (ro) Inhibitori biciclici micromoleculari ai trombinei
UA66865C2 (uk) Інденопіролокарбазоли, фармацевтична композиція, спосіб інгібування кіназної активності та спосіб лікування (варіанти)
DK0966447T3 (da) Anvendelige små molekyler til behandling af betændelsessygdomme
WO2003057225A3 (en) Phosphate transport inhibitors
DK0813525T3 (da) Benzamidinderivater, deres fremstilling og anvendelse som antikoagulanter
NO872863D0 (no) Analogifremgangsmaate for fremstilling av terapeutiske imidazoler som blokkerer angiotensin-ii-reseptorer.
DK0923570T3 (da) Pyridylalken- og pyridylalkynsyreamider som cytostatiske og immunosuppresive midler
DK1107794T3 (da) Terapeutiske præparater til behandling af mucus-hypersekretion
MXPA03006855A (es) Metodo para tratar insuficiencia cardiaca cronica y/o niveles elevados de colesterol, utilizando acido 3,5-diyodotiropropionico, y metodo para su preparacion.
EA200301276A1 (ru) Новые производные сульфоновых кислот
DK1066056T4 (da) Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernmangel, fremgangsmåde til fremstilling af jerndextranforbindelsen og anvendelse af denne forbindelse til fremstilling af et...
FI103111B1 (fi) Menetelmä proteolyyttisen entsyymin inhibiittoreina käyttökelpoisten sakkariinijohdannaisten valmistamiseksi
DK0888271T3 (da) Benzamidinderivater substitueret med aminosyre- og hydroxysyrederivater og deres anvendelse som antikoagulerende midler
ATE273279T1 (de) 2,3,5-trisubstituierte pyridine als inhibitoren von cyclooxygenase-2
NO20051390L (no) Fremgangsmate for behandling av pasienter med massivt blodtap
AU551066B2 (en) Pyridyl substituted pyridylalkyleneamino pyrimidones
DK0556322T3 (da) Aminosulfonylurinstof-ACAT-inhibitorer
EA200000693A1 (ru) Антагонисты хемокинного рецептора и способы их применения
DK0996435T3 (da) Aminosyrederivater anvendelige til behandling af slagtilfælde
EA199800889A1 (ru) Способ предупреждения и/или лечения сердечной недостаточности и дисфункции желудочков антагонистами эндотелина, фармацевтическая композиция
EA200101205A1 (ru) Применение комбинации витаминов для лечения зуда и неинфекционных заболеваний, приводящих к зуду и/или воспалению
DK1152760T3 (da) Anvendelse af 4-aminopyridin til behandling af perifere neuropatier
ES534452A0 (es) Un procedimiento para preparar un derivado de primidona
ECSP992840A (es) Procedimiento para tratar la insuficiencia cardiaca